Dr. Hind ELMALIK is a Senior Consultant Oncologist at the National Center for Cancer Care & Research (NCCCR) at Hamad Medical Corporation in Doha, Qatar, with a special interest in gynecologic oncology.
Dr. Hind is a Sudanese American. Born in Khartoum, Sudan, where she had her early schooling, she then graduated from Qasr Al Aini in Cairo, Egypt. After a few years of rotation in various subspecialties, she joined the Arab Board Fellowship program in Internal Medicine at Hamad Medical Corporation (HMC) in Qatar and obtained her Certification in 2006.
In the same year, she also received her MRCP(UK). She then decided to pursue a career in Medical Oncology and completed the fellowship program at HMC, after which she was promoted to consultant in 2012. She then obtained the Certificate of the European Society of Medical Oncology and the Specialty in Medical Oncology from the Royal College of Physicians of the United Kingdom in 2015. She is an ESMO-certified oncologist
Dr. Elmalik was appointed as an Assistant Professor of Clinical Medicine at WCMQ (Weill Cornell Medical College in Qatar) in 2017.
She became interested in Breast and Gynecologic Oncology. She led the gynecologic oncology multidisciplinary team from the medical oncology side, overseeing a specialized joint gynecologic oncology clinic in collaboration with gynecology surgeons, as well as a breast oncology clinic.
Dr Hind Elmalik is an active member of several international gynecological groups, including ESGO, IGCS, ESMO, ASCO, EOTTD, ISTTD, PARSGO, and the Middle East and North Africa (MENA)/NCCN Ovarian Cancer Group.
Her research interests focus on gynecological cancer, with a special interest in Gestational Trophoblastic Disease GTD and she has several publications in this field. She is looking forward to establishing a database for women's cancer in collaboration with her colleagues from the Middle East and North Africa (MENA) region, as well as with colleagues from other parts of the world. She is frequently invited to speak at local and regional/international conferences. She participated twice in the Best of ASCO in Qatar, serving as a member of the scientific committee and as a speaker.
